Company page

Macrogenics, Inc.

Macrogenics, Inc. is a public biotechnology company based in the United States, trading under the ticker MGNX. The company focuses on developing innovative therapies for cancer and other serious diseases. With a market capitalization of approximately $262.5 million, Macrogenics is actively engaged in advancing its pipeline of therapeutic candidates.